02 December 2024
SOLASTA Bio raises $14m, plans to commercialize peptide-based biopesticides in ‘half the time’ it takes for synthetics
UK-based ag biotech startup SOLASTA Bio has closed a $14 million oversubscribed Series A round, bringing its total funding to $19 million
SOLASTA Bio raises $14m for peptide-based biopesticides: SOLASTA Bio raises $14m, plans to commercialize peptide-based biopesticides in ‘half the time’ it takes for syntheticsMore articles
16 January 2026
SOLASTA Bio placed in ‘Ones to Watch’ feature of the The Sunday Times 100 Tech, Britain’s fastest-growing private technology companies
12 December 2025
New Ag International: SOLASTA Bio announces new peptide patents
“These patent grants represent a paradigm shift in crop protection, demonstrating that nature-inspired peptides can be effectively protected for commercial deployment,” says Shireen Davies, CEO and co-founder of SOLASTA Bio. “The ...